Loading...

Horizon Therapeutics Public Limited Company Peer Comparison

Metric Value Ranking
Market Cap $26.6 Billion 12/12 LLY
$828.7B
JNJ
$373.8B
ABBV
$341.1B
AZN
$230.8B
MRK
$216.7B
NVS
$211.3B
AMGN
$158.6B
GILD
$128.8B
SNY
$124.1B
BMY
$113.9B
GSK
$75.4B
HZNP
$26.6B
Gross Margin 77% 3/12 LLY
82%
MRK
80%
HZNP
77%
AZN
77%
BMY
75%
NVS
75%
GSK
74%
ABBV
71%
JNJ
70%
SNY
68%
AMGN
61%
GILD
-100%
Profit Margin 13% 7/12 AMGN
33%
LLY
33%
NVS
21%
MRK
19%
GILD
17%
GSK
15%
HZNP
13%
JNJ
12%
ABBV
11%
AZN
11%
SNY
11%
BMY
10%
EBITDA margin 15% 11/12 ABBV
49%
LLY
45%
BMY
38%
NVS
38%
GSK
33%
JNJ
32%
AZN
30%
SNY
26%
MRK
25%
AMGN
24%
HZNP
15%
GILD
12%
Quarterly Revenue $945.0 Million 12/12 SNY
$23.3B
JNJ
$22.5B
MRK
$16.7B
ABBV
$14.5B
AZN
$13.6B
NVS
$13.6B
LLY
$13.5B
BMY
$11.9B
GSK
$10.1B
AMGN
$8.5B
GILD
$7.6B
HZNP
$945.0M
Quarterly Earnings $127.1 Million 12/12 LLY
$4.4B
MRK
$3.2B
AMGN
$2.8B
NVS
$2.8B
JNJ
$2.7B
SNY
$2.5B
ABBV
$1.6B
GSK
$1.5B
AZN
$1.4B
GILD
$1.3B
BMY
$1.2B
HZNP
$127.1M
Quarterly Free Cash Flow $291.8 Million 9/12 MRK
$8.5B
BMY
$5.3B
ABBV
$5.2B
GILD
$4.5B
AMGN
$3.3B
NVS
$3.1B
AZN
$2.0B
GSK
$564.1M
HZNP
$291.8M
JNJ
-$0
LLY
-$0
SNY
-$553.8M
Trailing 4 Quarters Revenue $3.6 Billion 12/12 JNJ
$87.7B
SNY
$74.6B
MRK
$63.2B
ABBV
$55.5B
AZN
$51.2B
NVS
$50.7B
BMY
$47.4B
LLY
$45.0B
GSK
$40.3B
AMGN
$32.5B
GILD
$28.3B
HZNP
$3.6B
Trailing 4 Quarters Earnings $438.0 Million 10/12 SNY
$23.3B
JNJ
$22.5B
MRK
$16.7B
ABBV
$14.5B
AZN
$13.6B
NVS
$13.6B
LLY
$13.5B
BMY
$11.9B
GSK
$10.1B
AMGN
$8.5B
GILD
$7.6B
HZNP
$945.0M
Quarterly Earnings Growth 108% 1/12 HZNP
108%
LLY
101%
AMGN
64%
SNY
57%
AZN
4%
ABBV
-12%
GSK
-28%
MRK
-33%
BMY
-37%
GILD
-43%
NVS
-67%
JNJ
-90%
Annual Earnings Growth -35% 8/12 LLY
425%
MRK
192%
SNY
6%
AZN
-5%
NVS
-13%
AMGN
-28%
GSK
-34%
HZNP
-35%
ABBV
-35%
JNJ
-65%
GILD
-98%
BMY
-189%
Quarterly Revenue Growth 8% 7/12 SNY
99%
LLY
45%
AMGN
23%
AZN
18%
NVS
15%
GSK
10%
HZNP
8%
BMY
8%
GILD
7%
JNJ
5%
ABBV
4%
MRK
4%
Annual Revenue Growth 3% 9/12 SNY
57%
LLY
19%
AMGN
17%
GSK
12%
AZN
12%
BMY
6%
NVS
6%
GILD
5%
HZNP
3%
MRK
3%
ABBV
0%
JNJ
-10%
Cash On Hand $2.5 Billion 9/12 MRK
$14.6B
NVS
$11.5B
AMGN
$9.0B
BMY
$7.9B
SNY
$7.5B
ABBV
$7.3B
AZN
$4.8B
GSK
$3.8B
HZNP
$2.5B
GILD
-$0
JNJ
-$0
LLY
-$0
Short Term Debt $16.0 Million 9/12 ABBV
$12.6B
SNY
$10.5B
NVS
$8.3B
GSK
$4.3B
AMGN
$3.5B
MRK
$3.1B
AZN
$1.6B
BMY
$1.1B
HZNP
$16.0M
GILD
-$0
JNJ
-$0
LLY
-$0
Long Term Debt $2.5 Billion 9/12 ABBV
$58.5B
AMGN
$56.9B
BMY
$48.7B
MRK
$35.0B
AZN
$30.0B
NVS
$22.9B
GSK
$17.4B
SNY
$13.7B
HZNP
$2.5B
GILD
$0
JNJ
$0
LLY
$0
PE 60.74 4/12 GILD
1021.84
LLY
78.26
ABBV
66.51
HZNP
60.74
AMGN
37.50
AZN
35.54
JNJ
25.46
MRK
17.84
NVS
17.70
GSK
14.58
SNY
14.35
BMY
-1.00
PS 7.30 2/12 LLY
18.40
HZNP
7.30
ABBV
6.14
AMGN
4.88
GILD
4.55
AZN
4.51
JNJ
4.26
NVS
4.17
MRK
3.43
BMY
2.40
SNY
1.51
GSK
1.46
PB 5.01 7/12 LLY
57.87
ABBV
56.18
AMGN
21.07
BMY
6.62
AZN
5.66
JNJ
5.23
HZNP
5.01
MRK
4.86
NVS
4.79
GSK
4.27
GILD
3.01
SNY
1.55
PC 10.79 9/12 AZN
48.12
ABBV
47.00
GSK
19.86
NVS
18.44
AMGN
17.60
SNY
16.62
MRK
14.85
BMY
14.43
HZNP
10.79
GILD
-1.00
JNJ
-1.00
LLY
-1.00
Liabilities to Equity 0.75 9/12 ABBV
22.77
AMGN
11.07
BMY
4.46
GSK
3.08
MRK
1.64
AZN
1.57
NVS
1.32
SNY
0.78
HZNP
0.75
GILD
0.00
JNJ
-1.00
LLY
-1.00
ROA 0.05 6/12 NVS
12%
MRK
10%
GSK
9%
SNY
7%
AZN
6%
HZNP
5%
AMGN
5%
ABBV
4%
GILD
0%
BMY
-8%
JNJ
-100%
LLY
-100%
ROE 0.08 10/12 ABBV
85%
LLY
74%
AMGN
56%
GSK
36%
MRK
27%
NVS
27%
JNJ
21%
AZN
16%
SNY
12%
HZNP
8%
BMY
-42%
GILD
-100%
Current Ratio 2.33 2/12 GILD
4.65
HZNP
2.33
SNY
2.29
NVS
1.76
AZN
1.64
MRK
1.61
GSK
1.31
BMY
1.22
AMGN
1.09
ABBV
1.04
JNJ
0.00
LLY
0.00
Quick Ratio 0.62 1/12 GILD
1021.84
LLY
78.26
ABBV
66.51
HZNP
60.74
AMGN
37.50
AZN
35.54
JNJ
25.46
MRK
17.84
NVS
17.70
GSK
14.58
SNY
14.35
BMY
-1.00
Long Term Debt to Equity 0.48 8/12 ABBV}
9.70
AMGN}
7.55
BMY}
2.84
GSK}
0.94
MRK}
0.79
AZN}
0.74
NVS}
0.52
HZNP}
0.48
SNY}
0.17
JNJ}
0.00
LLY}
0.00
GILD}
-1.00
Debt to Equity 0.48 8/12 ABBV
11.78
AMGN
8.02
BMY
2.90
GSK
1.18
MRK
0.86
AZN
0.78
NVS
0.71
HZNP
0.48
SNY
0.33
JNJ
0.00
LLY
0.00
GILD
-1.00
Burn Rate -115.10 12/12 NVS
63.53
AZN
29.40
AMGN
27.29
SNY
16.54
BMY
7.85
ABBV
1.85
GILD
0.00
JNJ
0.00
LLY
0.00
MRK
-15.04
GSK
-24.84
HZNP
-115.10
Cash to Cap 0.09 1/12 HZNP
0.09
BMY
0.07
MRK
0.07
AMGN
0.06
SNY
0.06
GSK
0.05
NVS
0.05
ABBV
0.02
AZN
0.02
GILD
0.00
JNJ
0.00
LLY
0.00
CCR 2.30 5/12 BMY
4.35
GILD
3.63
ABBV
3.33
MRK
2.69
HZNP
2.30
AZN
1.42
AMGN
1.17
NVS
1.09
GSK
0.38
JNJ
0.00
LLY
0.00
SNY
-0.22
EV to EBITDA 186.89 1/12 HZNP}
186.89
GILD}
144.99
LLY}
134.78
AMGN}
102.58
AZN}
62.79
MRK}
58.74
ABBV}
57.49
JNJ}
52.65
NVS}
44.55
GSK}
42.17
BMY}
34.02
SNY}
28.23
EV to Revenue 7.33 2/12 LLY
18.40
HZNP
7.33
ABBV
7.29
AMGN
6.46
AZN
5.03
NVS
4.56
GILD
4.55
JNJ
4.26
MRK
3.80
BMY
3.28
GSK
2.74
SNY
2.06